VICO.ST
Vicore Pharma Holding AB (publ)
StockholmSEKEQUITY
Healthcare
DELAYED
Last price
11.00
▼ 0.04 (0.36%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
10.90
Prev close
11.04
Day high
11.20
Day low
10.72
Volume
950.76K
Market cap
$3.10B
P/E (TTM)
—
52W range
8.62 – 18.24
Day trading desk
Gap from prior close
-1.27%
Prior close 11.04
VWAP
10.99
+0.12% from price
Relative volume
3.88×
Unusually busy
Session range
4.48%
10.72 – 11.20
Position in range
58%
Mid range
ATR (14D)
0.47
4.27% of price
Prior day high
11.24
PDH
Prior day low
10.94
PDL
Bid / ask spread
—
Quote not published
Session volume
2.67M
Avg 686.02K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.79%
-0.4%
1M
-1.61%
-5.3%
3M
-10.86%
-14.0%
6M
+6.18%
-4.9%
YTD
-2.65%
-14.9%
1Y
-0.36%
-20.4%
3Y
-30.99%
-105.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on VICO.ST open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
35.70M
Total on file
Fundamentals
Market cap$3.10B
Enterprise value$2.18B
Revenue (TTM)$3.99M
Gross profit$3.99M
EBITDA—
Net income$-502.04M
EPS (TTM)$-1.91
Free cash flow$-284.80M
Total cash$905.64M
Total debt$0
Book value / share$3.52
Shares outstanding281.53M
Float197.61M
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E-5.73
PEG ratio—
Price / sales—
Price / book3.13
EV / revenue544.64
EV / EBITDA—
Gross margin100.00%
Operating margin-6782.83%
Profit margin0.00%
Return on equity-56.99%
Return on assets-34.47%
Debt / equity—
Current ratio12.68
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.82M | $109.35M | $0 | $0 | -96.5% |
| Operating revenue | $3.82M | $109.35M | $0 | $0 | -96.5% |
| Gross profit | $3.82M | $109.35M | $0 | $0 | -96.5% |
| Research & development | $390.35M | $249.26M | $276.29M | $249.97M | +56.6% |
| Selling, general & admin | $67.91M | $50.44M | $44.59M | $37.53M | +34.6% |
| Total operating expense | $458.26M | $299.71M | $320.89M | $287.49M | +52.9% |
| Operating income | -$454.44M | -$190.36M | -$320.89M | -$287.49M | -138.7% |
| Net interest income | $23.83M | $21.07M | $10.54M | $905.00K | +13.1% |
| Pre-tax income | -$477.47M | -$168.89M | -$311.33M | -$288.81M | -182.7% |
| Tax provision | $0 | -$256.00K | -$384.00K | -$384.00K | +100.0% |
| Net income | -$477.47M | -$168.63M | -$310.94M | -$288.42M | -183.1% |
| Net income to common | -$477.47M | -$168.63M | -$310.94M | -$288.42M | -183.1% |
| Basic EPS | -1.99 | -1.23 | -3.18 | -3.88 | -61.8% |
| Diluted EPS | -1.99 | -1.23 | -3.18 | -3.88 | -61.8% |
| EBIT | -$477.41M | -$168.88M | -$311.32M | -$288.80M | -182.7% |
| EBITDA | -$477.41M | -$166.64M | -$307.90M | -$285.19M | -186.5% |
| Basic shares | 239.88M | 136.84M | 96.56M | 74.22M | +75.3% |
| Diluted shares | 239.88M | 136.84M | 96.56M | 74.22M | +75.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $578.15M | $1.16B | $333.62M | $256.80M | — | -50.0% |
| Cash & short-term investments | $1.17B | $1.16B | $482.66M | $261.74M | — | +0.9% |
| Total current assets | $1.22B | $1.20B | $495.60M | $269.79M | — | +1.8% |
| Property, plant & equipment | — | $0 | $25.00K | $54.00K | $84.00K | — |
| Goodwill & intangibles | $0 | $0 | $2.22M | $68.10M | — | — |
| Total assets | $1.22B | $1.20B | $497.84M | $338.01M | — | +1.9% |
| Total current liabilities | $118.43M | $65.69M | $40.96M | $46.42M | — | +80.3% |
| Total liabilities | $123.17M | $66.25M | $42.45M | $48.92M | — | +85.9% |
| Retained earnings | -$1.92B | -$1.44B | -$1.27B | -$962.65M | — | -33.2% |
| Shareholder equity | $1.10B | $1.13B | $455.39M | $289.08M | — | -3.0% |
| Working capital | $1.10B | $1.13B | $454.64M | $223.37M | — | -2.8% |
| Net tangible assets | $1.10B | $1.13B | $453.17M | $220.98M | — | -3.0% |
| Shares issued | 281.53M | 234.58M | 114.83M | 84.12M | — | +20.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$452.39M | -$194.19M | -$321.51M | -$290.73M | -133.0% |
| Depreciation & amortisation | $0 | $2.24M | $3.42M | $3.61M | -100.0% |
| Change in working capital | $40.81M | -$1.84M | -$10.65M | -$20.94M | +2,321.6% |
| Operating cash flow | -$375.74M | -$164.95M | -$249.58M | -$299.92M | -127.8% |
| Capital expenditure | — | — | — | -$3.00M | — |
| Investing cash flow | -$600.51M | $149.04M | -$144.46M | $74.00M | -502.9% |
| Financing cash flow | $430.54M | $834.06M | $470.86M | $187.04M | -48.4% |
| Free cash flow | -$375.74M | -$164.95M | -$249.58M | -$302.92M | -127.8% |
| End cash position | $578.15M | $1.16B | $333.62M | $256.80M | -50.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $602.00K | $419.00K | $1.75M | $892.00K | $5.10M | +43.7% |
| Operating revenue | $602.00K | $419.00K | $1.75M | $892.00K | $5.10M | +43.7% |
| Gross profit | $602.00K | $419.00K | $1.75M | $892.00K | $5.10M | +43.7% |
| Research & development | $102.59M | $113.04M | $99.42M | $78.73M | $81.60M | -9.2% |
| Selling, general & admin | $21.51M | $22.06M | $14.08M | $14.13M | $16.96M | -2.5% |
| Total operating expense | $124.45M | $134.13M | $112.92M | $92.44M | $99.19M | -7.2% |
| Operating income | -$123.84M | -$133.71M | -$111.17M | -$91.55M | -$94.09M | +7.4% |
| Net interest income | $15.31M | -$3.40M | -$4.19M | -$19.99M | $10.01M | +551.0% |
| Pre-tax income | -$108.53M | -$137.10M | -$115.36M | -$111.53M | -$84.08M | +20.8% |
| Tax provision | $86.00K | $0 | $0 | $0 | $0 | — |
| Net income | -$108.62M | -$137.10M | -$115.36M | -$111.53M | -$84.08M | +20.8% |
| Net income to common | -$108.62M | -$137.10M | -$115.36M | -$111.53M | -$84.08M | +20.8% |
| Basic EPS | -0.39 | -0.54 | -0.49 | -0.48 | -0.40 | +27.8% |
| Diluted EPS | -0.39 | -0.54 | -0.49 | -0.48 | -0.40 | +27.8% |
| EBIT | -$107.89M | -$128.56M | -$100.86M | -$85.13M | -$84.07M | +16.1% |
| EBITDA | -$107.89M | -$128.56M | -$100.86M | -$85.13M | -$84.07M | +16.1% |
| Basic shares | 281.53M | 255.76M | 234.58M | 234.58M | 207.73M | +10.1% |
| Diluted shares | 281.53M | 255.76M | 234.58M | 234.58M | 207.73M | +10.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $377.42M | $578.15M | $351.60M | $715.47M | $1.16B | -34.7% |
| Cash & short-term investments | $1.06B | $1.17B | $936.98M | $1.05B | $1.16B | -9.2% |
| Accounts receivable | $0 | — | — | $873.00K | — | — |
| Total current assets | $1.07B | $1.22B | $975.09M | $1.08B | $1.20B | -11.7% |
| Property, plant & equipment | — | — | $0 | $0 | $0 | — |
| Goodwill & intangibles | — | $0 | $0 | $0 | $0 | — |
| Total assets | $1.08B | $1.22B | $976.50M | $1.08B | $1.20B | -11.6% |
| Total current liabilities | $84.66M | $118.43M | $66.44M | $62.09M | $65.69M | -28.5% |
| Total liabilities | $86.35M | $123.17M | $68.25M | $63.08M | $66.25M | -29.9% |
| Retained earnings | — | -$1.92B | — | — | -$1.44B | — |
| Shareholder equity | $990.91M | $1.10B | $908.25M | $1.02B | $1.13B | -9.5% |
| Working capital | $989.59M | $1.10B | $908.65M | $1.02B | $1.13B | -9.9% |
| Net tangible assets | $990.91M | $1.10B | $908.25M | $1.02B | $1.13B | -9.5% |
| Shares issued | 281.53M | 281.53M | 234.61M | 234.58M | 234.58M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$123.84M | -$133.71M | -$111.17M | -$91.55M | -$94.09M | +7.4% |
| Change in working capital | $2.37M | $36.59M | -$600.00K | $2.57M | $23.97M | -93.5% |
| Operating cash flow | -$117.64M | -$81.48M | -$106.45M | -$86.11M | -$51.17M | -44.4% |
| Investing cash flow | -$88.66M | -$237.36M | -$250.29M | -$333.85M | $35.24M | +62.6% |
| Financing cash flow | $0 | $430.53M | $15.00K | $0 | $834.06M | -100.0% |
| Free cash flow | -$117.64M | -$81.48M | -$106.45M | -$86.11M | -$51.17M | -44.4% |
| End cash position | $377.42M | $578.15M | $351.60M | $715.47M | $1.16B | -34.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.45 | -0.51 | -13.3% |
| Mar 2026 | -0.48 | -0.39 | +18.8% |
| Dec 2025 | -0.46 | -0.54 | -18.4% |
| Sep 2025 | -0.46 | -0.48 | -4.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.49 | 2 | $563.00K | -25.9% |
| Next quarter | -0.50 | 2 | $563.00K | +34.4% |
| Current year | -1.94 | 3 | $10.37M | +171.8% |
| Next year | -1.39 | 4 | $60.24M | +480.8% |
Analyst targets & ownership
Mean target$29.25
High target$38.00
Low target$15.00
Implied upside165.91%
Analyst count4
ConsensusSTRONG BUY
Strong buy / Buy1 / 4
Hold0
Sell / Strong sell0 / 0
Held by insiders12.75%
Held by institutions59.51%
Institutions holding30
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
11.30
-2.69% from price
SMA 20
11.22
-1.93% from price
SMA 50
11.72
-6.13% from price
SMA 100
11.17
-1.48% from price
SMA 200
10.88
+1.15% from price
EMA 12
11.23
-2.05% from price
EMA 26
11.36
-3.18% from price
EMA 50
11.41
-3.62% from price
RSI (14)
43.8
Neutral
MACD (12,26,9)
-0.13
Hist -0.01
ATR (14)
0.47
4.27% of price
Realised vol 30D
32.4%
Annualised
Bollinger upper
11.73
20, 2σ
Bollinger lower
10.70
20, 2σ
50 / 200 cross
Golden
11.72 vs 10.88
Trend bias
Above 200
+1.15%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.30
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
32.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-31.4%
Peak to trough
Max drawdown 5Y
-82.9%
Peak to trough
ATR 14
0.47
4.27% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
The Committee for a Responsible Federal Budget Estimates Social Security Cuts for Couples if the System Is Not Fixed
Motley Fool · 14m ago
Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?
Insider Monkey · 15m ago
Liverpool striker Isak expected Newcastle abuse, says Iraola
AFP · 15m ago
Your mortgage rate has a growing problem in the bond market
TheStreet · 17m ago
Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?
Insider Monkey · 21m ago
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 24m ago
Vistra Is the Quietest Big Winner of the AI Power Boom. Here's Why.
Motley Fool · 25m ago
AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
Insider Monkey · 25m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.